Siteman Cancer Center — St Louis, Missouri

Public research footprint of Siteman Cancer Center, compiled from the ClinicalTrials.gov public registry.

802

Registered studies

339

Active

139

Recruiting now

344

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Anatomic Stage II Breast Cancer AJCC v8 · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6…

Recently updated registry entries

NCT06632977 — Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT05564390 — MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Siteman Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.